Xie, Yali <br/><br/>
A rifampicin-resistant (rpoB) mutation in Pseudomonas protegens Pf-5 strain leads to improved antifungal activity and elevated production of secondary metabolites.  [electronic resource] 

 -  Research in microbiology  Oct 2016 
 - 625-629 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1769-7123 
<br/><br/><label>Standard No.: </label>10.1016/j.resmic.2016.05.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibiosis<br/>Antibiotics, Antitubercular--pharmacology<br/>Antifungal Agents--metabolism<br/>Biological Products--metabolism<br/>Chromatography, High Pressure Liquid<br/>DNA-Directed RNA Polymerases--genetics<br/>Drug Resistance, Bacterial<br/>Mutation, Missense<br/>Pseudomonas--drug effects<br/>Rifampin--pharmacology<br/>Secondary Metabolism